Abstract
Experiments were performed in order to ascertain the action ofd-penicillamine (PA) on adjuvant arthritis (AA) in rats and to develop a quantitative evaluation method for PA-like drugs, using Lewis, SD, and Wistar rats. Rats were inoculated in the tail with 0.6 mg ofMycobacterium butyricum suspended in 0.1 ml of liquid paraffin. PA apparently induced enhancement of arthritis only in Lewis rats with a good reproducibility. The enhancing effect of PA was seen when it was administered during the period from day −7 to day −1, from day 0 to day 6, or from day 14 to day 20. In control group of Lewis and Wistar rats, adjuvant caused a rapid increase in the cell number of lymph nodes just after the inoculation, and also a marked increase in spleen cells coinciding with the development of arthritis. In PA-treated Lewis rats, the cell numbers of lymph nodes and spleen significantly surpassed those of control rats. However, PA induced no difference from control in Wistar rats, which were not sensitive to PA treatment during the course of arthritis. These results indicate that AA in Lewis rats is a good model for evaluating the activities of PA-like drugs and that PA may affect lymphocytes in lymph nodes and spleen and induce severer arthritis in Lewis rats.
Similar content being viewed by others
References
R.L. Dawkins, P.J. Zilko, J. Carrano, M.J. Garlepp andB.L. McDonald,Immunobiology of d-penicillamine, J. Rheumatol. (Suppl. 7)8, 51–56 (1981).
S. Otomo, S. Nakaike, I. Tsuji, C. Mori andM. Ohzeki,Studies of d-penicillamine (3): Immunomodulating effect of d-penicillamine, Folia pharmac. jap.77, 313–320 (1981).
H. Fujimura, Y. Hiramatsu, Y. Tamura, M. Yanagihara, A. Kouda, H. Nagai, K. Uda, T. Iso andH. Yamauchi,Pharmacological studies of new sulfhydryl compound 2-mercapto-2-methylpropanoyl-l-cysteine (SA96). Folia pharmac. jap.76, 117–129 (1980).
B. Klamer, E.T. Kimura andM. Makstenieks,Effects of oral cysteine, penicillamine and N-acetylpenicillamine on adjuvant arthritis in rats, Pharmacology1, 283–288 (1968).
R. Baumgartner, H. Obenaus andH.C. Staerk,Suppression of adjuvant arthritis by penicillamine in pyridoxine-deficient rats, Proc. Soc. exp. Biol. Med.146, 241–244 (1974).
A.J. Anderson,Lysosomal enzyme activity in rats with adjuvant-induced arthritis, Ann. rheum. Dis.29, 307–313 (1970).
S.P. Liyanage andH.L.F. Curry,Failure of oral d-penicillamine to modify adjuvant arthritis of immune response in the rat, Ann. rheum. Dis.31, 521 (1972).
S. Otomo, S. Higuchi, S. Nakaike, Y. Tarumoto, M. Kimura, M. Sasajima andM. Ohzeki,Studies of D-penicillamine (5): Effects on rat adjuvant arthritis, Folia pharmc. jap.78, 145–162 (1981).
E. Arrigoni-Martelli andE. Bramm,Investigations on the influence of cyclophosphamide, gold sodium thiomalate and d-penicillamine on nystatin oedema and adjuvant arthritis, Agents and Actions5, 264–267 (1975).
E. Arrigoni-Martelli, E. Bramm andL. Binderup,Immunostimulant activity of d-penicillamine, Drugs Exp. Clin. Res.2, 189–195 (1977).
M.L. Toivonen, O. Tokola andH. Vapaatalo,Rat adjuvant arthritis as a model to test potential antirheumatic agents, Methods Find. Exp. Clin. Pharmacol.4, 359–363 (1982).
A.D. Sedgwick, J.C.W. Edwards andD.A. Willoughby,The effect of d-penicillamine on non-immune responses to tissue injury. Int. J. Tiss. Reac.5, Rehabil.15, 207–210 (1976).
Y. Ohsugi, S.-I. Hata, M. Tanemura, T. Nakano, T. Matsuno, Y. Takagaki, Y. Nishi andM. Shindo,N-(2-Carboxyphenyl)-4-chloroantranilic acid disodium salt: a novel anti-arthritic agent without anti-inflammatory and immunosuppressive activities, J. Pharm. Pharmac.29, 636–637 (1979).
M.W. Whitehouse, I.R. Garrett, B. Vernon-Roberts andP.M. Brooks,Ambivalent effects of anti-arthritic gold drugs on experimental polyarthritis in rats, Int. J. Immunopharmacol.4, 325 (1982).
C.M. Pearson,Experimental joint disease. Observations on adjuvant-induced arthritis, J. Chronic. Dis16, 863–874 (1963).
H. Berry, D.A. Willoughby andJ.P. Giroud,Evidence for an endogenous antigen in the adjuvant arthritic rat, J. Path.III, 229–238 (1973).
L. Binderup, E. Bramm andE. Arrigoni-Martelli,Immunological effects of d-penicillamine during experimentally induced inflammation in rats, Scand. J. Immunol.12, 239–247 (1980).
E. Bramm, L. Binderup andE. Arrigoni-Martelli,Delayed hypersensitivity to tuberculin in rats: effects of antirheumatic drug, Acta pharamac. tox.44, 75–80 (1979).
E. Arrigoni-Martelli andE. Bramm,Development of models for penicillamine-like drugs, Rheumatol. Rehabil.15, 207–210 (1976).
P. Merryman andI.A. Jaffe,Effect of penicillamine on the proliferative response of human lymphocytes, Proc. Soc. exp. Biol. Med.157, 155–158 (1978).
K. Kayashima, T. Koga andK. Onoue,Role of T lymphocytes. I. Evidence for the regulatory function of thymus-derived cells in the induction of the disease, J. Immun.117, 1878–1882 (1976).
K. Kayashima, T. Koga andK. Onoue,Role of T lymphocytes. II. Different subpopulations of T lymphocytes functioning in the development of the disease, J. Immun.120, 1127–1131 (1978).
J.D. Taurog, Studies of the cellular basis of adjuvant arthritis in the rat. InAdvances in Inflammation Research, Vol. 7, pp. 161–170 (Ed. G. Weissmann) Raven Press, New York 1984.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakaike, S., Takeshita, K., Shiono, M. et al. Studies ofd-penicillamine on strain variability and lymph node cellularity in adjuvant arthritis. Agents and Actions 16, 514–520 (1985). https://doi.org/10.1007/BF01983656
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01983656